Soligenix Stock News

Rani Therapeutics (NASDAQ:RANI) and Soligenix (NASDAQ:SNGX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Analyst Recommendations This is a breakdown of current ratings and recommmendations for Rani Therapeutics and Soligenix, […]

Soligenix, Inc. (NASDAQ:SNGX) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 1,210,000 shares, an increase of 19.8% from the November 15th total of 1,010,000 shares. Based on an average trading volume of 1,690,000 shares, the days-to-cover ratio is presently 0.7 days. SNGX [] The post Short Interest in Soligenix, Inc. (NASDAQ:SNGX) Expands By 19.8% appeared first on ETF Daily News .

Soligenix (NASDAQ:SNGX) and CURE Pharmaceutical (OTCMKTS:CURR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability. Profitability This table compares Soligenix and CURE Pharmaceuticals net margins, return on equity and return on []

ReWalk Robotics Ltd. (NASDAQ:RWLK) with the stream of 2.40% also noticed, India Soligenix, Inc. (NASDAQ:SNGX) encountered a rapid change of 4.14% in the last hour of Wednesdays trading session. ReWalk The post Have a gripe on this: ReWalk Robotics Ltd. (NASDAQ:RWLK), Soligenix, Inc. (NASDAQ:SNGX) appeared first on Stocks Equity .

Soligenix, Inc. (NASDAQ:SNGX) with the stream of -2.09% also noticed, India Fury Gold Mines Limited (AMEX:FURY) encountered a rapid change of -3.05% in the last hour of Fridays trading session. The post Lookout for Price Target? Soligenix, Inc. (NASDAQ:SNGX), Fury Gold Mines Limited (AMEX:FURY) appeared first on Stocks Equity .

Sonnet BioTherapeutics Holdings, Inc. (SONN) with the stream of -10.85% also noticed, India Soligenix, Inc. (SNGX) encountered a rapid change of 2.54% in the last hour of Fridays trading session. The post Hesitation to buy this Stock might leave you disappointed: Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), Soligenix, Inc. (NASDAQ:SNGX) appeared first on Stocks Equity .

AMC Entertainment Holdings, Inc. (AMC) with the stream of -3.24% also noticed, India Soligenix, Inc. (SNGX) encountered a rapid change of 3.23% in the last hour of Fridays trading session. The post Revenue Approximations Analysis: AMC Entertainment Holdings, Inc. (NYSE:AMC), Soligenix, Inc. (NASDAQ:SNGX) appeared first on Stocks Equity .

Soligenix, Inc. (NASDAQ:SNGX) Equities research analysts at Zacks Investment Research upped their FY2021 earnings estimates for shares of Soligenix in a research report issued to clients and investors on Monday, November 22nd. Zacks Investment Research analyst D. Bautz now anticipates that the biopharmaceutical company will post earnings of ($0.31) per share for the year, []

Color Star Technology Co., Ltd. (CSCW) with the stream of -2.26% also noticed, India Soligenix, Inc. (SNGX) encountered a rapid change of 0.12% in the last hour of Fridays trading The post Comparable Company Analysis: Color Star Technology Co., Ltd. (NASDAQ:CSCW), Soligenix, Inc. (NASDAQ:SNGX) appeared first on Stocks Equity .

In an SEC filing, Soligenix Inc (NASDAQ: SNGX) disclosed that it cannot file its HyBryte marketing application in the U.S. in 1H of 2022. Citing COVID-19 related disruptions resulting in delays by

Dr. Chris Schaber Discusses Soligenix HyBryte(TM) and Thermostabilized VaccinesNew York, New York--(Newsfile Corp. - October 13, 2021) - PCG Digital -- In a recent interview with Kristen Kluska, a bio

PRINCETON, N.J., Oct. 12, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to

PRINCETON, N.J., Sept. 28, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to

PRINCETON, N.J., Sept. 27, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to